Funded Tech Companies
RareCyte
RareCyte is a biopharmaceutical company, based in Seattle. Investment was provided by Agilent Technologies, HealthQuest Capital and F-Prime Capital.
Company Overview
Company Name
RareCyte
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
2601 4th Ave.
Seattle, WA 98121
USA
Seattle, WA 98121
USA
Phone
Website
Email Address
Company Background Information
Overview
RareCyte is a life science research and diagnostic development company focused on characterizing and isolating rare cells in the blood. Our team of biologists and engineers is dedicated to building innovative technologies to better understand human health and disease.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/13/2021
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Joe Victor
Chief Medical Officer
Eric Kaldjian
VP - Bus. Development
Leighton Howells
VP - Engineering
Steve Reese
VP - Finance
James Cooper
VP - Operations
Tony Dedeo
VP - Product Management
Josh Nordberg
VP - R & D
Tad George
Company Investors
- Agilent Technologies
- HealthQuest Capital (David Kabakoff)
- F-Prime Capital (Robert Weisskoff)
- 5AM Ventures (Andrew Schwab)
- Logos Capital
- Arboretum Ventures
- Private Investors (Ron Seubert)
- Private Investors (Ronald Seubert)
- Telegraph Hill Partners (Robert Shepler)
- 5AM Ventures (Joe Victor)
Browse more funded tech companies:
RareCircles | Rarefied Technologies
Share this article
About Our Venture Capital Database
The company data above is provided by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs